Ryman Healthcare Limited (RHCGF)

PNK: RHCGF · Real-Time Price · USD

1.41

-1.70 (-54.66%)

At close: May 01, 2025, 8:00 PM

Ryman Healthcare Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q2 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019
Revenue	632.37M	513.6M	585.76M	567.84M	529M	609.25M	597.1M	499.4M	510.79M	477.58M	435.69M	403.1M	257.33M	129.8M
Cost of Revenue	651.34M	501.97M	577.14M	551.63M	521.55M	611.01M	596.28M	508.33M	505.82M	468.8M	416.83M	372.57M	230.26M	114.42M
Gross Profit	-18.97M	11.64M	8.62M	16.21M	7.45M	-1.76M	823.94K	-8.93M	4.97M	8.78M	18.86M	30.53M	27.07M	15.38M
Operating Income	-29.34M	-6.77M	-4.99M	3.5M	-5.27M	-6.43M	-3.85M	-8.93M	4.97M	8.78M	18.86M	30.53M	27.07M	15.38M
Interest Income	17.13M	22.7M	23.18M	16.09M	15.53M	9.27M	8.18M	232.6K	36.68K	97.49K	256.45K	392.96K	332.15K	144.22K
Pretax Income	-66.59M	-133.47M	31.93M	119.53M	155.1M	421.33M	617.67M	621.2M	638.31M	468.52M	264.56M	248.62M	108.16M	122.73M
Net Income	59.9M	57.33M	151.68M	229.43M	226.03M	453.93M	608.16M	587.89M	626.91M	482.12M	333.24M	303.77M	163.37M	118.06M
Selling & General & Admin	-1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research & Development	9.89M	9.89M	8.75M	7.4M	7.4M	7.4M	3.73M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	1.00	1.00	2.00	2.00	1.00	1.00	0.00	0.00	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	123.53M	164.97M	181.08M	124.05M	147.24M	105.8M	84.88M	63.65M	n/a	n/a	n/a	n/a	n/a	n/a
Interest Expense	64.06M	30.31M	129.4M	129.4M	127.22M	137.9M	32.03M	32.03M	28.05M	23.71M	18.97M	18.11M	11.77M	5.99M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	255.91M	626.47M	696.83M	614.3M	584.22M	632.24M	617.51M	508.33M	505.82M	468.8M	416.83M	372.57M	230.26M	114.42M
Income Tax Expense	-4.88M	-42.64M	-25.92M	-35.76M	3.21M	15M	57.11M	33.31M	11.4M	-13.59M	-68.68M	-55.15M	-55.21M	4.67M
Shares Outstanding (Basic)	741.14M	687.65M	687.65M	687.64M	687.65M	573.17M	532.65M	530.46M	530.46M	530.46M	530.46M	530.46M	530.46M	530.46M
Shares Outstanding (Diluted)	741.14M	687.64M	687.64M	687.64M	687.64M	573.17M	532.65M	530.46M	530.46M	530.46M	530.46M	530.46M	530.46M	530.46M
EPS (Basic)	0.08	0.08	0.23	0.35	0.39	0.85	1.15	1.11	1.19	0.91	0.63	0.57	0.31	0.22
EPS (Diluted)	0.08	0.08	0.23	0.35	0.39	0.85	1.15	1.11	1.19	0.91	0.63	0.57	0.31	0.22
EBITDA	277.51M	125.02M	130.05M	133.83M	21.12M	24.86M	33.4M	27.93M	41.36M	41.05M	47.63M	56.21M	44.51M	24M
EBIT	237.03M	93.19M	101.41M	109.9M	143.29M	143.25M	139.83M	134.74M	4.83M	10.99M	15.48M	20.85M	13.92M	7.84M
Depreciation & Amortization	40.48M	31.83M	43.02M	38.32M	35.48M	40.39M	37.94M	37.55M	36.39M	34.37M	30.87M	27.79M	17.44M	8.62M